Living Rheum
Dedicated to uncovering clinical developments and treatment advancements in the field of rheumatology, Living Rheum delivers expert insights on patient management across a broad spectrum of rheumatic diseases, such as rheumatoid arthritis, lupus, scleroderma, osteoporosis, and more.
16-30 of 77
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Living RheumShared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Living RheumCan We Prevent Psoriatic Arthritis Before Diagnosis?
Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living RheumDecoding the Data: Early Biologic Use and Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living RheumDefining the Challenge in Complex Cases of Psoriatic Arthritis
Laura Coates, MBChB, MRCP, PhD
Molecular Signals and Early Detection in Psoriatic Arthritis
Living RheumMolecular Signals and Early Detection in Psoriatic Arthritis
Navigating the Modern PsA Treatment Landscape
Living RheumNavigating the Modern PsA Treatment Landscape
- advertisement
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living RheumRethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living RheumUnderstanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Ryan Quigley
Luigi Adamo, MD, PhD
Andrea Fava, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living RheumExploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living RheumCadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Ryan Quigley
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living RheumDelaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
- advertisement
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living RheumImproving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Sjögren’s Disease Management: A Decade in Review
Living RheumSjögren’s Disease Management: A Decade in Review
Early Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
Living RheumEarly Rituximab Use in Sjögren’s Syndrome: A Meta-Analysis Review
